Multistakeholder workshop to launch consultation on European Medicines Agency (EMA) human regulatory science to 2025
The European Medicines Agency (EMA) is holding a multi-stakeholder workshop on 24 October 2018 to gather initial thoughts on the key areas for human medicines to be covered in EMA’s regulatory science to 2025.
This should facilitate a shared reflection on the key regulatory science challenges faced by the Agency's scientific committees and working parties and the opportunities to address them, an understanding of the process leading to the proposed strategic goals and core recommendations, and highlighting areas of particular relevance to various stakeholder groups in order to focus on them during the public consultation.
Participants will include patient representatives, healthcare professionals, academic infrastructures, health technology assessment (HTA) bodies, payer organisations, trade associations and regulators.
The event is by invitation only to allow for a balanced representation of the various groups of stakeholders. It will be broadcast and recorded for all interested parties to follow the proceedings.
Note that you should see the live broadcast or the message 'We are currently not broadcasting' below, on this page. If the area below is black or in case of difficulties viewing the broadcast, please try connecting directly to our Ustream channel: European Medicines Agency or try viewing from an unrestricted connection, for example over wifi or 3G. For technical information about the required network security settings, please see this Ustream help page.
We recommend to press the 'HD' symbol on the player and select the option '720' to obtain the best quality of the video. For further assistance, please consult the Ustream Help Center